Figure 2.

Overall survival curves of patients in the propensity score matching cohort. (A): For individuals with tumor size ≤5 cm, the 1‐, 3‐, and 5‐year overall survival rates were 90.1%, 66.4%, and 50.9%, respectively, in the group without adjuvant treatment and 91.8%, 76.1%, and 72.4%, respectively, in the group with adjuvant treatment. (B): For individuals with tumor size >5 cm, the 1‐, 3‐, and 5‐year overall survival rates were 87.5%, 39.2%, and 24.9%, respectively, in the group without adjuvant treatment and 60.5%, 39.1%, and 32.3%, respectively, in the group with adjuvant treatment.

Abbreviations: OS, overall survival; PA‐TACE, postoperative adjuvant transarterial chemoembolization.